Table 4.
Correlation between changes in glucose infusion rate at euglycemic-hyperinsulinemic clamp and clinical variables in patients treated with liraglutide.
| r | P value | |
|---|---|---|
| Changes in body mass index | −0.086 | 0.760 |
| Changes in hemoglobin A1c (%) | −0.101 | 0.710 |
| Changes in fasting blood glucose (mg/dL) | −0.165 | 0.540 |
| Changes in fasting blood insulin (µU/mL) | 0.128 | 0.650 |
| Changes in fasting blood CPR (ng/mL) | −0.154 | 0.583 |
| Changes in postprandial blood glucose (mg/dL) | −0.383 | 0.143 |
| Changes in postprandial blood insulin (µU/mL) | 0.067 | 0.819 |
| Changes in postprandial blood CPR (ng/mL) | −0.293 | 0.309 |
CPR: C-peptide radioimmunoreactivity.